SCHEMBL7879896

SCHEMBL7879896

CCN(CC)Cc1ccc(Oc2cc(C(F)(F)F)c3cc(C(=O)N=C(N)NC)[nH]c3c2)s1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 1/20 0.32
SLC9A1 P19634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880191 0.92 RHEB (0.33) RHEBSLC9A1
SCHEMBL7882109 0.89 RHEB (0.34) RHEBSLC9A1
SCHEMBL7880072 0.88 RHEB (0.31) RHEB
SCHEMBL7880994 0.85 KMT2A (0.34)
SCHEMBL7879952 0.85 RHEB (0.35) RHEB
SCHEMBL7873847 0.84 RHEB (0.35) RHEBSLC9A1
SCHEMBL7879509 0.84 RHEB (0.32) RHEB
SCHEMBL7879495 0.84 HRH3 (0.32) RHEB
SCHEMBL7873429 0.84 SLC9A1 (0.32) SLC9A1
SCHEMBL7879893 0.84 RHEB (0.32) RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed